Sponsor:
Cogent Biosciences, Inc.
Code:
NCT07361562
Conditions
Advanced Solid Tumor, Adult
ERBB2 Altered Breast Cancer
ERBB2 Gene Amplification
HER2 Overexpression
Non-Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CGT4255
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-30. This information was provided to ClinicalTrials.gov by Cogent Biosciences, Inc. on 2026-01-23.